BioCentury | Aug 3, 2015
Clinical News

BTL-TML-HSV: Phase I/II data

...procedure (Phase IIa, n=171) or induced by UV light (Phase IIb, n=305) showed that sublingual BTL-TML-HSV...
...>50% of patients experiencing a prodrome. Beech is seeking a partner to continue development of BTL-TML-HSV...
...I/IIa trial (see BioCentury, April 15, 2013). Beech Tree Labs Inc. , Providence, R.I. Product: BTL-TML-HSV...
BioCentury | Apr 15, 2013
Clinical News

BTL-TML-HSV: Phase I/IIa data

...tingling, burning, itching or presence of a lesion following a dental procedure showed that sublingual BTL-TML-HSV...
...the placebo arm contributed "in large part" to the lack of significance on the endpoint. BTL-TML-HSV...
...The trial enrolled 171 patients, of which 31 progressed to prodrome and initiated treatment with BTL-TML-HSV...
BioCentury | Jul 19, 2010
Clinical News

BTL-TML-HSV: Phase I/IIa start

...placebo-controlled Phase I/IIa trial in 210 patients. Beech Tree Labs Inc. , Providence, R.I. Product: BTL-TML-HSV...
Items per page:
1 - 3 of 3